vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2026-1-235-241vtio-2000Research ArticleИмплантаты и искусственные органыImplants and Artificial OrgansЦилиндрический протез для трикуспидальной позиции: возможности и недостатки имплантатаCylindrical prosthetic valves for the tricuspid position: prospects and limitationsБабенкоС. И.BabenkoS. I.

Москва

Moscow

СачковА. С.SachkovA. S.

Москва

Moscow

БритиковД. В.BritikovD. V.

Москва

Moscow

https://orcid.org/0000-0001-7892-368XСоркомовМ. Н.SorkomovM. N.

Соркомов Максим Нюргустанович

121552, Москва, Рублевское шоссе, д. 135. Тел. (495) 414-78-49

Maxim Sorkomov

135, Rublevskoe shosse, Moscow, 121552

Phone: (495) 414-78-49

sorcommn@gmail.comМуратовР. Р.MuratovR. R.

Москва

Moscow

ХайитматовИ. С.KhayitmatovI. S.

Москва

Moscow

ТитовД. А.TitovD. A.

Москва

Moscow

ФГБУ «Национальный медицинский исследовательский центр сердечно-сосудистой хирургии имени А.Н. Бакулева» Минздрава РоссииBakulev National Medical Research Center for Cardiovascular Surgery202631032026281235241Copyright © Бабенко С.И., Сачков А.С., Бритиков Д.В., Соркомов М.Н., Муратов Р.Р., Хайитматов И.С., Титов Д.А., 20262026Бабенко С.И., Сачков А.С., Бритиков Д.В., Соркомов М.Н., Муратов Р.Р., Хайитматов И.С., Титов Д.А.Babenko S.I., Sachkov A.S., Britikov D.V., Sorkomov M.N., Muratov R.R., Khayitmatov I.S., Titov D.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/2000

Протезирование трикуспидального клапана при первичной недостаточности достаточно редкая операция. Протезом выбора остается биологический протез, поскольку он не требует антикоагулянтной терапии, и как ожидалось, подвержен более медленной дегенерации, чем в митральной или аортальной позиции. Однако срок службы протезов все же ограничен, особенно это касается молодых пациентов. Механические протезы требуют жесткой антикоагулянтной терапии в связи с достаточно низким кровотоком в правых отделах серд ца. Наиболее сложная ситуация при выборе протеза у пациентов с инфекционным эндокардитом и абсцессом фиброзного кольца. Целью исследования было проанализировать результаты экспериментальных исследований цилиндрического протеза и первого клинического опыта в мировой практике. Создание новых моделей протезов с использованием инертного и более долговечного материала позволит решить проблемы имплантата для трикуспидальной позиции, оптимизировать операционный процесс и улучшить качество жизни пациентов в отдаленном периоде.

Tricuspid valve (TV) replacement for primary regurgitation is a relatively rare procedure. Bioprosthetic valves are generally preferred because they do not require anticoagulant therapy and tend to degenerate more slowly in the tricuspid position than in the mitral or aortic positions; however, their durability remains limited, particularly in young patients. In contrast, mechanical prosthetic valves require rigorous anticoagulant therapy due to low blood flow in the right heart chambers. Prosthesis selection is especially challenging in cases of infective endocarditis with fibrous annular abscess. The aim of this study is to analyze experimental data on cylinder valves and to review the first clinical experiences reported worldwide. The development of new prosthesis models using inert and more durable materials may address current limitations of TV implants, optimize surgical techniques, and improve patient quality of life in the long-term.

недостаточность трикуспидального клапанацилиндрический протезбиопротезированиеинфекционный эндокардитtricuspid regurgitationcylinder valvesbioprosthetic valvesinfective endocarditisReferencesCox JL, Ad N, Myers K, Gharib M, Quijano RC. Tubular heart valves: a new tissue prosthesis design – preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg. 2005 Aug; 130 (2): 520–527.Cox JL, Ad N, Myers K, Gharib M, Quijano RC. Tubular heart valves: a new tissue prosthesis design – preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg. 2005 Aug; 130 (2): 520–527.Fallon AM, Goodchild TT, Cox JL, Matheny RG. In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model. J Thorac Cardiovasc Surg. 2014 Jul; 148 (1): 333–340.e1.Fallon AM, Goodchild TT, Cox JL, Matheny RG. In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model. J Thorac Cardiovasc Surg. 2014 Jul; 148 (1): 333–340.e1.Ropcke DM, Ilkjær C, Skov SN, Tjørnild MJ, Sørensen AV, Jensen H et al. Functional and Biomechanical Performance of Stentless Extracellular Matrix Tricuspid Tube Graft: An Acute Experimental Porcine Evaluation. Ann Thorac Surg. 2016 Jan; 101 (1): 125–132.Ropcke DM, Ilkjær C, Skov SN, Tjørnild MJ, Sørensen AV, Jensen H et al. Functional and Biomechanical Performance of Stentless Extracellular Matrix Tricuspid Tube Graft: An Acute Experimental Porcine Evaluation. Ann Thorac Surg. 2016 Jan; 101 (1): 125–132.Hsu CPD, Mirzaa A, Mathenyb R, Ramaswamya S. Tricuspid Versus Mitral Performance of Cylindrical Porcine Small Intestinal Submucosa Valves. Structural Heart. 2021; 5 (1): 74. https://doi/org/10.1080/24748706.21.Hsu CPD, Mirzaa A, Mathenyb R, Ramaswamya S. Tricuspid Versus Mitral Performance of Cylindrical Porcine Small Intestinal Submucosa Valves. Structural Heart. 2021; 5 (1): 74. https://doi/org/10.1080/24748706.21.Murala JSK, Sassalos P, Owens ST, Ohye RG. Porcine small intestine submucosa cylinder valve for mitral and tricuspid valve replacement. J Thorac Cardiovasc Surg. 2017 Sep; 154 (3): e57–e59. https://doi.org/10.1016/j.jtcvs.2017.03.129.Murala JSK, Sassalos P, Owens ST, Ohye RG. Porcine small intestine submucosa cylinder valve for mitral and tricuspid valve replacement. J Thorac Cardiovasc Surg. 2017 Sep; 154 (3): e57–e59. https://doi.org/10.1016/j.jtcvs.2017.03.129.Veiseh O, Vegas AJ. Domesticating the foreign body response: Recent advances and applications. Adv Drug Deliv Rev. 2019 Apr; 144: 148–161.Veiseh O, Vegas AJ. Domesticating the foreign body response: Recent advances and applications. Adv Drug Deliv Rev. 2019 Apr; 144: 148–161.Xue AH, Sarkeshik A, Boyd WD, Perry P. Tricuspid Valve Replacement Using CorMatrix® Extracellular Matrix Cylindrical Construct. CTSNet, Inc. Media. 2019. https://doi.org/10.25373/ctsnet.9793169.v2.Xue AH, Sarkeshik A, Boyd WD, Perry P. Tricuspid Valve Replacement Using CorMatrix® Extracellular Matrix Cylindrical Construct. CTSNet, Inc. Media. 2019. https://doi.org/10.25373/ctsnet.9793169.v2.Kasravi M, Ahmadi A, Babajani A, Mazloomnejad R, Hatamnejad MR, Shariatzadeh S et al. Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine. Biomater Res. 2023 Feb 9; 27 (1): 10. doi: 10.1186/s40824-023-00348-z.Kasravi M, Ahmadi A, Babajani A, Mazloomnejad R, Hatamnejad MR, Shariatzadeh S et al. Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine. Biomater Res. 2023 Feb 9; 27 (1): 10. doi: 10.1186/s40824-023-00348-z.Gerdisch MW, Boyd WD, Harlan JL, Richardson JB Jr, Flack JE 3rd, Palafox BA et al. Early experience treating tricuspid valve endocarditis with a novel extracellular matrix cylinder reconstruction. J Thorac Cardiovasc Surg. 2014 Dec; 148 (6): 3042–3048.Gerdisch MW, Boyd WD, Harlan JL, Richardson JB Jr, Flack JE 3rd, Palafox BA et al. Early experience treating tricuspid valve endocarditis with a novel extracellular matrix cylinder reconstruction. J Thorac Cardiovasc Surg. 2014 Dec; 148 (6): 3042–3048.Бабенко СИ, Муратов РМ, Соркомов МН. Современные тенденции в создании бесклеточных алло- и ксенотканей для реконструкции структур сердц а. Вестник трансплантологии и искусственных органов. 2021; 23 (1): 150–156. https://doi.org/10.15825/1995-1191-2021-1-150-156.Babenko SI, Muratov RM, Sorcomov MN. Current trends in the creation of cellfree allo- and xenotissues for reconstruction of heart structures. Russian Journal of Transplantology and Artificial Organs. 2021; 23 (1): 150–156. https://doi.org/10.15825/1995-1191-2021-1-150-156.Бритиков ДВ, Акатов ВС, Чащин ИС, Зубко АВ, Муратов РМ. Эволюция подходов к жизнеспособности и девитализации аллографтов и разработка нового метода децеллюляризации. Клеточная модификация аллографтов. Клиническая физиология кровообращения. 2021; 2 (18): 118–127. doi: 10.24022/1814-6910-2021-18-2-128-138.Britikov DV, Akatov VS, Chashchin IS, Zubko AV, Muratov RM. The evolution of approaches to the viability and devitalization of allografts and the development of a new decellularization method. Cellular modification of allografts. Clinical physiology of blood circulation. 2021; 2 (18): 118–127. doi: 10.24022/1814-6910-2021-18-2-128-138.Padalino MA, Quarti A, Angeli E, Frigo AC, Vida VL, Pozzi M et al. Early and mid-term clinical experience with extracellular matrix scaffold for congenital cardiac and vascular reconstructive surgery: a multicentric Italian study. Interact Cardiovasc Thorac Surg. 2015 Jul; 21 (1):40–49. https://doi.org/10.1093/icvts/ivv076.Padalino MA, Quarti A, Angeli E, Frigo AC, Vida VL, Pozzi M et al. Early and mid-term clinical experience with extracellular matrix scaffold for congenital cardiac and vascular reconstructive surgery: a multicentric Italian study. Interact Cardiovasc Thorac Surg. 2015 Jul; 21 (1):40–49. https://doi.org/10.1093/icvts/ivv076.Zaidi AH, Nathan M, Emani S, Baird C, del Nido PJ, Gauvreau K et al. Preliminary experience with porcine intestinal submucosa (CorMatrix) for valve reconstruction in congenital heart disease: Histologic evaluation of explanted valves. J Thorac Cardiovasc Surg. 2014 Nov; 148 (5): 2216–2225.e1. https://doi.org/10.1016/j.jtcvs.2014.02.081.Zaidi AH, Nathan M, Emani S, Baird C, del Nido PJ, Gauvreau K et al. Preliminary experience with porcine intestinal submucosa (CorMatrix) for valve reconstruction in congenital heart disease: Histologic evaluation of explanted valves. J Thorac Cardiovasc Surg. 2014 Nov; 148 (5): 2216–2225.e1. https://doi.org/10.1016/j.jtcvs.2014.02.081.Miyamoto S, Shinoka T, Kobayashi K. A Novel Template and Cylinder Bioprosthetic Atrioventricular Valve: An Ex Vivo Study. Ann Thorac Surg Short Rep. 2023 Sep 17; 1 (4): 642–646.Miyamoto S, Shinoka T, Kobayashi K. A Novel Template and Cylinder Bioprosthetic Atrioventricular Valve: An Ex Vivo Study. Ann Thorac Surg Short Rep. 2023 Sep 17; 1 (4): 642–646.Charkiewicz-Szeremeta K, Matlak K, Garbowska M, Hirnle G, Kralisz P, Kocañda S, Hirnle T. Infective endocarditis of the tricuspid valve. Surgical treatment with pericardial cylinder implantation. Kardiochir Torakochirurgia Pol. 2023 Apr 3; 20 (1): 18–23. doi: 10.5114/kitp.2023.126094.Charkiewicz-Szeremeta K, Matlak K, Garbowska M, Hirnle G, Kralisz P, Kocañda S, Hirnle T. Infective endocarditis of the tricuspid valve. Surgical treatment with pericardial cylinder implantation. Kardiochir Torakochirurgia Pol. 2023 Apr 3; 20 (1): 18–23. doi: 10.5114/kitp.2023.126094.

The authors declare that there are no conflicts of interest present.